Q2 2025 Bausch + Lomb Corp Earnings Call Transcript
Key Points
- Bausch & Lomb Corp (BLCO) reported a 3% year-over-year revenue growth in Q2 2025, with a significant contribution from the Vision Care segment.
- The company achieved a 6% revenue growth in its Vision Care segment, driven by strong performance in consumer and contact lenses.
- The dry eye portfolio saw a 16% constant currency revenue growth, with standout performances from products like LUMIFY and Artelac.
- Bausch & Lomb Corp (BLCO) successfully refinanced $3.1 billion of its debt, extending maturities to 2031 with minimal impact on interest expenses.
- The company raised its full-year revenue guidance to a range of $5.05 billion to $5.15 billion, reflecting confidence in business performance and currency tailwinds.
- The enVista recall had a significant impact, reducing the Surgical segment's growth from a potential 15% to 1% in Q2.
- The US Generics business declined by 29% in the quarter, negatively affecting overall Pharmaceutical segment performance.
- Adjusted gross margin decreased by 130 basis points year-over-year, impacted by the enVista recall and product mix.
- The company faced challenges with tariffs, although efforts were made to mitigate the impact, resulting in an estimated 40 basis points impact for 2025.
- Despite strong prescription growth, the Pharmaceutical segment's performance was hindered by gross-to-net headwinds and competition in the dry eye market.
Good morning, and welcome to Bausch + Lomb's second quarter 2025 earnings call (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to George Gadkowski, Vice President of Investor Relations and Business Insights. Please go ahead.
+-
Thank you. Good morning, everyone, and welcome to our second quarter 2025 financial results conference call. Participating on today's call are Chairman and Chief Executive Officer, Mr. Brent Saunders; and Chief Financial Officer, Mr. Sam Eldessouky.
In addition to this live webcast, a copy of today's slide presentation and a replay of this conference call will be available on our website under the Investor Relations section. Before we begin, I would like to remind you that our presentation today contains forward-looking information.
We would ask that you take a moment to read the forward-looking legend at the beginning of our presentation as it contains important
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
